NCT04188899 Point-of-care Ultrasound in the Assessment of Snake Bite
| NCT ID | NCT04188899 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Arizona |
| Condition | Rattlesnake Bite (Diagnosis) |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2019-11-28 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2019-11-28 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Early identification of tissue injury from a rattlesnake bite is critical to prevent complications and reduce health care costs. Given the limitations of clinical assessment, there is a need to develop a more objective reproducible, anatomically detailed diagnostic tool for to accurately assess tissue damage and assist with timely administration of antivenom, if needed. Emergency physician performed point-of-care ultrasonography has been shown to be beneficial in the diagnosis and management of skin and soft tissue infections. The innovative use of bedside ultrasound technology can provide new information to individualize antivenom treatment and to improve patient outcomes. The objectives of this study is to compare clinical assessment and bedside ultrasound findings in the detection of tissue injury in emergency department patients with rattle snakebite and determine if bedside ultrasound can alter management (antivenom dosing) in emergency department patients with rattle snakebite.
Eligibility Criteria
Inclusion Criteria: * Adult patients (18 years and older) * Both genders * Complaint of snake bite Exclusion Criteria: * If they are unwilling to provide informed consent * Hemodynamically unstable patients (shock respiratory distress, altered mental status, and cardiorespiratory arrest) * All vulnerable patient populations, e.g., children, pregnant patients, prisoners, and patients unable to verbally consent due to cognitive impairment
Contact & Investigator
Srikar Adhikari, MD, MS
PRINCIPAL INVESTIGATOR
University of Arizona
Frequently Asked Questions
Who can join the NCT04188899 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Rattlesnake Bite (Diagnosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04188899 currently recruiting?
Yes, NCT04188899 is actively recruiting participants. Contact the research team at sadhikari@aemrc.arizona.edu for enrollment information.
Where is the NCT04188899 trial being conducted?
This trial is being conducted at Tucson, United States.
Who is sponsoring the NCT04188899 clinical trial?
NCT04188899 is sponsored by University of Arizona. The principal investigator is Srikar Adhikari, MD, MS at University of Arizona. The trial plans to enroll 150 participants.